MedTrace Logo

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

NCT00392262 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2016-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with amlodipine or felodipine alone.

Conditions

Interventions

DRUG

valsartan + amlodipine

Sponsors & Collaborators

Principal Investigators

  • Novartis +41 61 324 1111 · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-02-28
Completion
2007-02-28

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00392262 on ClinicalTrials.gov